Progression free survival by the treatment with Cabozatinib in a case of BRAF mutated Radioiodine refractory recurrent metastatic Papillary Carcinoma Thyroid. Bangladesh J of Otorhinolaryngology [Internet]. 2026 Apr. 21 [cited 2026 Jun. 29];31(2):86-94. Available from: https://www.banglajol.info/index.php/BJO/article/view/89000